2/3
07:23 am
cdna
CareDx to Present AlloHeme™ Pivotal Clinical Validation Data in Hematologic Cancer Relapse Detection at 2026 Tandem Meetings [Yahoo! Finance]
Low
Report
CareDx to Present AlloHeme™ Pivotal Clinical Validation Data in Hematologic Cancer Relapse Detection at 2026 Tandem Meetings [Yahoo! Finance]
2/3
07:05 am
cdna
CareDx to Present AlloHeme™ Pivotal Clinical Validation Data in Hematologic Cancer Relapse Detection at 2026 Tandem Meetings
Low
Report
CareDx to Present AlloHeme™ Pivotal Clinical Validation Data in Hematologic Cancer Relapse Detection at 2026 Tandem Meetings
2/1
03:42 am
cdna
CareDx's CEO Conducts Multiple Sale of Shares Towards the End of January 2026 [Yahoo! Finance]
Low
Report
CareDx's CEO Conducts Multiple Sale of Shares Towards the End of January 2026 [Yahoo! Finance]
1/31
05:22 am
cdna
Did Strong 2025 Revenue Growth and 10x Genomics Deal Just Shift CareDx's (CDNA) Investment Narrative? [Yahoo! Finance]
Low
Report
Did Strong 2025 Revenue Growth and 10x Genomics Deal Just Shift CareDx's (CDNA) Investment Narrative? [Yahoo! Finance]
1/30
10:38 am
cdna
CareDx President and CEO Sells 19,000 Shares for $412,000 [Yahoo! Finance]
Low
Report
CareDx President and CEO Sells 19,000 Shares for $412,000 [Yahoo! Finance]
1/27
05:16 pm
cdna
CareDx to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference [Yahoo! Finance]
Medium
Report
CareDx to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference [Yahoo! Finance]
1/27
04:05 pm
cdna
CareDx to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Low
Report
CareDx to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
1/12
07:20 am
cdna
CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
High
Report
CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
1/12
07:05 am
cdna
CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results
High
Report
CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results
1/7
07:21 am
cdna
CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response [Yahoo! Finance]
Low
Report
CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response [Yahoo! Finance]
1/7
07:05 am
cdna
CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response
Low
Report
CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response
1/6
08:06 am
cdna
CareDx (NASDAQ:CDNA) was downgraded by analysts at Craig Hallum from a "buy" rating to a "hold" rating.
Low
Report
CareDx (NASDAQ:CDNA) was downgraded by analysts at Craig Hallum from a "buy" rating to a "hold" rating.
12/26
04:05 pm
cdna
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12/22
10:17 am
cdna
CareDX Has Reached An Inflection Point, But Regulatory Risks Remain (Upgrade) [Seeking Alpha]
Low
Report
CareDX Has Reached An Inflection Point, But Regulatory Risks Remain (Upgrade) [Seeking Alpha]
12/21
01:08 am
cdna
Low
Report
12/18
05:45 pm
cdna
CareDx Provides Notice of Proposed Derivative Settlement [Yahoo! Finance]
Low
Report
CareDx Provides Notice of Proposed Derivative Settlement [Yahoo! Finance]
12/18
05:00 pm
cdna
CareDx Provides Notice of Proposed Derivative Settlement
Low
Report
CareDx Provides Notice of Proposed Derivative Settlement
12/15
08:43 am
cdna
CareDx (NASDAQ:CDNA) was given a new $18.00 price target on by analysts at Wells Fargo & Company.
Low
Report
CareDx (NASDAQ:CDNA) was given a new $18.00 price target on by analysts at Wells Fargo & Company.
12/14
12:17 pm
cdna
CareDx (CDNA): Rethinking Valuation After a Sharp Short-Term Share Price Rebound [Yahoo! Finance]
Medium
Report
CareDx (CDNA): Rethinking Valuation After a Sharp Short-Term Share Price Rebound [Yahoo! Finance]
11/24
04:05 pm
cdna
SHORE Study Demonstrates HeartCare's Prognostic Value for Heart Transplant Recipients, Published in Journal of Heart and Lung Transplantation
Low
Report
SHORE Study Demonstrates HeartCare's Prognostic Value for Heart Transplant Recipients, Published in Journal of Heart and Lung Transplantation
11/20
01:33 pm
cdna
CareDx (NASDAQ:CDNA) had its "hold (c-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
CareDx (NASDAQ:CDNA) had its "hold (c-)" rating reaffirmed by analysts at
Weiss Ratings.
11/20
06:01 am
cdna
CareDx (NASDAQ:CDNA) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Low
Report
CareDx (NASDAQ:CDNA) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.